A subset of human acute lymphoblastic leukemias are driven by mutations of the interleukin-7 receptor (IL7R) and cytokine receptor-like factor 2 (CRLF2), causing aberrant signaling due to disulfide-mediated receptor activation.…
Read More
Congratulations to Paolo for being selected as American-Italian Cancer Foundation Fellow! For more than 30 years, AICF has supported both improved patient care and innovative cancer research, and we are grateful for…
Read MoreMechanisms of cancer drug susceptibility and resistance, lecture for the SKI/Cornell Pharmacology Graduate Program, May 2014: pdf
Read MoreEdwin M. Stone (edwin-stone[at]uiowa.edu) Reproduced with permission The basics your mother taught you: work hard, obey the golden rule, put some data in your book every day, read the literature,…
Read More(Bio)chemical proteomics, lecture for the SKI/Cornell Pharmacology Graduate Program, October 2013: pdf
Read MoreA novel plasma DNA testing strategy in Ewing #sarcoma, enabled by #mskimpact @sloankettering:… https://t.co/SDxIHtaHWV
Yet another example of this, wonder if RAG/AID induced? Somatic mutations in patients with rheumatoid arthritis https://t.co/MY6XaGA697
Exciting news, reminds me of the original excitement surrounding this work with Kathy Borden:… https://t.co/GrDtpKGNJR
.@leancerchietti & @drsarahruth found that a drug used to treat hepatitis C may inhibit #lymphoma cell growth.… https://t.co/NvnOs72i0a
New preprint from our lab... The polyploid state plays a tumor suppressive role in the liver https://t.co/3XhcDFG2e9
Another marvelous example of convergent retroviral gene domestication by @CedricFeschotte et al #MobDNA17
